Jemina tablets [dysmenorrhea] (ジェミーナ配合錠［月経困難症］)

Country: Japan

Language: English

Source: すりの適正使用協議会 RAD-AR Council, Japan

Active ingredient:

Levonorgestrel; Ethinylestradiol

Available from:

Nobelpharma Co., Ltd.

INN (International Name):

Levonorgestrel; Ethinylestradiol

Pharmaceutical form:

white tablet, diameter: 6.1 mm, thickness: 3.2 mm

Product summary:

Print on wrapping: ［28 tablet sheet］（face）Jemina、28錠、ジェミーナ配合錠、（back）28錠
［21 tablet sheet］（face）Jemina、21錠、ジェミーナ配合錠、（back）21錠

Patient Information leaflet

Drug Information Sheet("Kusuri-no-Shiori")
Internal
Revised: 04/2022
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
JEMINA TABLETS [DYSMENORRHEA]
ACTIVE INGREDIENT:
Levonorgestrel
Ethinylestradiol
DOSAGE FORM:
white tablet, diameter: 6.1 mm, thickness: 3.2 mm
IMPRINT OR PRINT ON WRAPPING:
［28 tablet sheet］（face）Jemina、28 錠、
ジェミーナ配合錠、（back）28 錠
［21 tablet sheet］（face）Jemina、21 錠、ジェミーナ配
合錠、（back）21 錠
EFFECTS OF THIS MEDICINE
This medicine reduces pain at menses by suppressing production of
prostaglandin which
causes pain through inhibition of ovulation and preventing endometrium
from thickening.
It is usually used to treat dysmenorrhea. You cannot use this medicine
for contraception.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you are or have the following : breast cancer/endometrial
cancer/cancer of the uterine
cervix or suspicion of these malignancies, undiagnosed abnormal
genital bleeding,
thrombophlebitis/pulmonary embolism/cerebrovascular disorder/coronary
artery disease or
histories of these conditions, smoking habit, migraine, heart valve
disease, diabetes,
thrombotic predisposition (including family members), antiphospholipid
antibody syndrome,
within 4 weeks before surgery, within 2 weeks after surgery, within 4
weeks after delivery,
long-term bed rest, liver disorder, liver tumor, abnormal lipid
metabolism, hypertension,
otosclerosis, or histories of jaundice/persistent itching or
gestational her